Document gEEraXwZK2GZ9LNeJ8MEL80EJ

Ares(202312005452-20/03/2023 | ENV) Subject ow: eeting ith 30JENIN tober follow up documents & course of action SFernotm::Wce1d0n8easdNaUy-,002R80SEeAptAeumrebler 2E022E13:36 To mmm com> re coco. ee-- Subject: (EXTERNAL Re: Meeting with 5MESI: sc6oo Friday7 morning. oear Sorry for the delay in replying. Thursday 6 in the moming would be fine. |EE. i copy, will get in contact with you for the preparations. Thanks and looking forward to the discussion, Aurel FSrenotm:JWednesday, September 28, 202c2 o12:14 ocsf C108ANU-00RDEA Aurel (ENm){nESoNns I RE: Meeting with 3M << <2. Thursday6or Friday 7 morning Dear Mr. Ciobanu-Dorde/a Dear Aurel, w1 woouullddhalivkee taonyfoalvlaoiwl-aubiplotynttohimseeemtaiwlithsoenutrJto youinetarolwynasntexwteewke.ekW?eWowuerled wpoenrdhaeprsinTghuwrhsedtahyermoyronuing (ca8l:e3n0d-a9r:.30) or Friday work for you? Please let me know what would be the timeslots free in your /Wmeatweoruilaldsloikre tsotrtaatlekgiacbovualtutehcehastirnasteigniEcuerxoepceutainodn ionfntohveatgiroenean denal:/gsielmaproecrhtaonrcaletoefrnsapteicvieasl.ty Tchheemicals objective of this meeting is to exchange with you re. strategy & policy coordination. Thank you foyourattention and apologies fo short notice but | think can baveery valuable exchange. Kind regards, 3M Sere, Applied toLife." \ Ior com rSentoJTuesoday 2m0 September 20221510 oTod, COMNG.DORDEA Aurel -- Spucb eetng win occewonenr Mon3dOcatobyer afternoon, o Wed afternoon Dear ir. Giobanu Dodea/ Dear Aurel, thawnaksyvoeruyaicneomreeYtoiurngonyoeua2n5daacvhariy ovfeAhmdiCshcuassmioEn.U Eniranment Commie arly September wViemeekahcheinig obuetFollyoowuin5g umpo rEoeIWESN) c1hbewiithrEsU CsomtmhieswioeneekrosfBtheeto3.n7&SOcntkobeevr.ivThsat a ateic ve alu chain in Eauropeo, arndeachoievientgothTGareehn aala owerlls PasAgreAemeTntsOgol. We JRualvaendeeJohonawnoaulddipeprfeoccaotntomaelessmeeertiaonndscoonDtilneuveelthweediashceusasdionswairtheyooru.thAMSeLJEoirnk efese i ocking at novation and investment word-wweihavde 20000 employees Eres Thank you to let me know whether you would be available and what day/time. J-- aM ScApipelniceed.to Life." Er er ona on or BNcox cSTioern FNC HOLE Foro t: Thursday 28 July 2022 01: 31 _... RG con Crotognasni;CHCRODBPANEGRDORDEA Aurel Pm Subec: RE. Thank you alow up fom discussion TDeoaarrkoyorukfor- follwing up. 1 te[J e os provide you withthe materials. My apologies for nFoetsensclwuchinag tbonomcrThoeatstaen.y comments or questions onthe ater, nappy otalowrugrwits Yloouokanodrywouaersdoarcaot Ynoutr ciotnnhveendiisecnucsesion ) Thanks rSeanmtsWviknoeosnuyFo2r7.ks20J 02 92E 50 N2I c coN nncu> To amtete co oCScCurocpsi. rconueeCiHICLODBPATNURDONDE Ae] i... `Subject: [EXTERNAL] RE: Thank you - follow up from discussion ese eo ID tdwravsawepltsesurre meting you ndyour colleagues ndamappreciative or the informative exchange hAhsiecetxhlrFaeanemedds,hradroiisvncgiuswnsiitoohfnsRmEayArCeCHoa,lnlge1oa1ig0nu6gekswoienllcthhearrcgonofcfetptthsodfseposesnecnitaifaela.ursgmeumhaentndtashnaptvrhoevoievdertdooskeyepodsutremgbaaulrt,d|idngd eattvscahwmetnet maylouvremran oYfoutnot3e1apmraesyewmaition Hreosmenodut tmoeaGllUncoglYeoaugeweesr rceofne.riTngan1ksvoaun. Wpeoshal sayin contact Foka FPareia FvIeNrKeHOOIER EEu aPer CSoommirgegitoonananment LE -- rSeonnWednesan 20, 008 5:47 Pcoz cToor FNCHOOUER Fora (ENV con occucrac con Sues hank you. Tolow up fom discussion s Dear Ms. Fink-Hooijer - Thank you again for our discussion early July about the EU Green Deal, EU Industrial Policy and the need for specialty chemicals to achieve EU strategic objectives (green, digital, resilient / strategic autonomy). I would like to stress again 3M's support for a strong single market and the EU Green Deal objectives, including the zero-pollution ambition. Recalling our discussion on the need for companies to have certainty and balanced future legislation to plan investment, I would like to reiterate the following points: Regulating PFAS requires pragmatism ("smart grouping"): The EC should not embark into banning all PFAS without a full understanding of its broad impact. There is a need for closing the data gap as to which PFAS poses an unacceptable risk to the environment or health, and for ensuring that the EU industry has the time to develop suitable alternatives. We would like to ask the EC to consider an alternative (grouping) approach for regulating PFAS. For example, a decision tree based on risk assessment, starting with the analysis of (eco)toxicological profile of relevant PFAS and their use, would be useful. Durable products will require persistent materials (contribution to circular economy): Many products need the functionality provided by individual PFAS to be durable and perform over time under demanding, sometimes extreme, conditions. Despite the negative perception currently assigned to the persistence of PFAS, it can be beneficial as it enables critical performance, durability and functionality of the application. Persistence can also support the circular economy's approach (performance = less materials needed, durability = less waste generated). Substitution will take time and will be challenging for some applications. Some applications (especially industrial ones) will have more difficulties with replacing PFAS than others without compromising on the safety and performance. Inertness and durability are key requirements for certain applications, and such functionality cannot be easily substituted with non-PFAS alternatives. In cases where durability is required, an alternative would very likely also be persistent. Health science on PFAS is not settled. While "legacy PFAS" like PFOA and PFOS can bioaccumulate in humans, it is key to recognize that these legacy PFAS-substances are no longer manufactured or used in Europe and their levels have been steadily dropping since the past 20 years. It is equally important to acknowledge that scientific evidence demonstrates no cause-and-effect relationship for any of the studied effects at levels people are exposed to. As a matter of fact, there is a large safety margin between the no-observed-adverse-effect level (NOAEL) assessed in laboratory animals and the measured levels in humans or nature. Need to distinguish between legacy PFAS and modern Fluoro-chemistries. While legacy PFAS such as PFOA and PFOS have been found to bioaccumulate in humans, this is not true for the shorter chain PFAS and other PFAS structures (e.g. fluoropolymers). Human biomonitoring results continue demonstrating this as well. PFAS emissions in the environment can be controlled and will be further limited. 3M committed to reduce PFAS discharges by more than 99% by 2024. In addition, we are working with downstream users and industry partners to control emissions throughout the life cycle of products (closed systems, recovery, recycling). I look forward to continuing our discussion and thank you for any feedback. I attach for your information the final version of the 3M presentation from our meeting. Sincerely, 4 3M Science. Applied to Life." Eo )and Deveopment 3ODfoMfbcCieeen+to1er8r|e5s1Bidg 220-7W-02 | St. Paul, MN 55144-1000 s